Leslie, William D. http://orcid.org/0000-0002-1056-1691
Schousboe, John T.
Morin, Suzanne N.
Martineau, Patrick
Lix, Lisa M.
Johansson, Helena
McCloskey, Eugene V.
Harvey, Nicholas C.
Kanis, John A. http://orcid.org/0000-0002-3129-4326
Article History
Received: 24 March 2020
Accepted: 19 June 2020
First Online: 25 June 2020
Compliance with ethical standards
:
: John Schousboe: Nothing to declare in context of this paper; ad hoc consultancy to Hologic, Inc.Suzanne Morin: Nothing to declare for the context of this paper, but has received research grants: Amgen.Eugene McCloskey: Nothing to declare for the context of this paper, but numerous ad hoc consultancies/speaking honoraria and/or research funding from Amgen, Bayer, General Electric, GSK, Hologic, Lilly, Merck Research Labs, Novartis, Novo Nordisk, Nycomed, Ono, Pfizer, ProStrakan, Roche, Sanofi-Aventis, Servier, Tethys, UBS and Warner-Chilcott.Nicholas Harvey: Nothing to declare for the context of this paper, but has received consultancy/lecture fees/honoraria/grant funding from Alliance for Better Bone Health, Amgen, MSD, Eli Lilly, Servier, Shire, Consilient Healthcare, Radius Health, UCB, Kyowa Kirin and Internis Pharma.John A. Kanis: Grants from Amgen, Lilly, Radius Health and non-financial support from Medimaps outside the submitted work.William Leslie, Patrick Martineau, Lisa Lix, Helena Johansson: No conflicts of interest.